AANG Holdings Group Member
LockSign is a patented digital signature solution designed to guarantee authenticity, prevent forgery, and protect against unauthorized duplication. Unlike traditional e-signatures that can be copied or manipulated, LockSign embeds a unique, encrypted QR code directly into each signature.
This QR code integrates both user-specific credentials and document-specific identifiers, ensuring that every signature is tied exclusively to the individual signer and the exact document being signed. Through this approach, LockSign combines advanced encryption with proprietary encoding methods to create a non-replicable digital fingerprint for every transaction.
Verification is simple and universal: any LockSign signature can be scanned and instantly authenticated through the platform, confirming the signer’s identity, the document’s integrity, and the date of signing. This ensures tamper-proof, legally binding, and regulator-compliant digital agreements.
Cancer BioBank is a next-generation biobank dedicated to the collection, processing, cryopreservation, and molecular profiling of tumor tissues and blood-derived samples to advance personalized oncology. Each sample is paired with rich pre-analytical, clinical, and research metadata, enabling studies on disease evolution, therapy response, and chemoresistance prediction.
This biobank provides high-quality biospecimens and data to hospitals, researchers, and pharmaceutical companies, accelerating biomarker discovery, diagnostic validation, and clinical innovation. With GDPR-compliant Dynamic Consent from Metabio, donors maintain transparent and ongoing control over how their samples are used.
The result is a trusted, tamper-traceable, and clinically relevant biobank that addresses critical gaps in Southeast Europe and beyond, advancing precision diagnostics, guiding treatment selection, and strengthening the oncology research ecosystem.
3D Exprimere is a pioneering 3D printing company in Greece, dedicated to transforming ideas into tangible, high-quality products through cutting-edge additive manufacturing. As part of the AAnG Holdings Group, it combines innovation with precision to deliver advanced 3D solutions for businesses, healthcare, and creative industries.
Unlike traditional production methods that can be costly and time-consuming, 3D Exprimere uses state-of-the-art printing technologies and specialized expertise to create customized models, prototypes, and end-use products with unmatched flexibility and accuracy. From medical models and corporate gifts to decorative objects and industrial parts, every project is tailored to meet specific client needs.
The process is seamless and scalable: physical objects can be digitized with 3D scanning, personalized designs can be produced on demand, and final products are delivered with consistency and quality assurance. This ensures efficient, sustainable, and innovative solutions that redefine how organizations and individuals approach manufacturing and design.
The next generation of connected health solutions calls for a unified biomedical IoT platform that enables remote patient monitoring across web and mobile, seamlessly integrating with medical devices, environmental sensors, and fitness trackers. By leveraging IoT data, it can optimize treatment adherence, deliver personalized digital services for chronic conditions and older adults, and provide behavioral monitoring to identify at-risk patients through event analysis. Advanced features like context-aware medical visualization, decision support systems, and blockchain-powered security ensure reliability, privacy, and actionable insights for truly modern, distributed healthcare.
AAnG is an entrepreneurial holdings group, investing passionately in innovative companies, promising ideas and technologies, and talented people. We focus on data management, digital solutions, tech and energy innovation, growth-oriented services, and education. We embrace a multi-node leadership and management model where a solid governance structure, operational agility, and business creativity coexist. As a holding group, we generate value through the human capital and talent we attract and the companies we develop around it. We identify potential, actively foster it, create opportunities, and inject know-how into our investments.
We use cookies to improve your browsing experience, analyze our traffic, and provide certain features. By clicking “Accept all,” you consent to the use of cookies in accordance with our Privacy Policy.
